Medical Tubing and Extrusion

Medical tubing and extrusion technologies

teleflex

Teleflex enrolls first patient in dual-drug-eluting device study of coronary interventions for diabetes

By

Teleflex (NYSE:TFX) announced today that it enrolled the first patient in its DUBSTENT DIABETES trial. The randomized, investigator-initiated trial evaluates a dual-device strategy for percutaneous coronary intervention (PCI) in patients with diabetes mellitus. DUBSTENT DIABETES investigates the safety and efficacy of combining drug-coated … [Read more...] about Teleflex enrolls first patient in dual-drug-eluting device study of coronary interventions for diabetes

Teleflex completes acquisition of Biotronik’s Vascular Intervention business

By

Teleflex [WtwhTicker symbol="TFX"](NYSE: TFX)[/WtwhTicker] announced today that it completed its previously announced acquisition of the Biotronik Vascular Intervention (VI) business. As part of strategy shifts by both companies, Teleflex in February agreed to acquire substantially all of the Biotronik VI unit. The acquisition adds a broad … [Read more...] about Teleflex completes acquisition of Biotronik’s Vascular Intervention business

Teleflex has positive Arrow catheter data

By

Teleflex reports new findings from a study showing the efficacy of its Arrow chlorhexidine-impregnated central venous catheters (CVCs).  The prospective study cohort included more than 6,670 patients from 12 intensive care units (ICUs). It spanned eight hospitals across India, Malaysia, Papua New Guinea, Colombia, Egypt and Turkey. Wayne, … [Read more...] about Teleflex has positive Arrow catheter data

Biotronik shifts strategy to focus on implantable devices

By

Biotronik today announced a strategic shift that includes the divestiture of its Vascular Intervention (VI) business to Teleflex. This deal comes as part of a major change at Teleflex, too, as the company today announced plans to separate into two separate businesses. Biotronik said its shift aims to strengthen its leadership in active … [Read more...] about Biotronik shifts strategy to focus on implantable devices

Teleflex to separate into two publicly traded companies

By

Teleflex [WtwhTicker symbol="TFX"](NYSE: TFX)[/WtwhTicker] announced today that it plans to separate its Urology, Acute Care and OEM businesses into a new publicly traded company. The company's board authorized management to pursue a plan to separate the businesses via a distribution of newly issued shares of "NewCo" to shareholders that is … [Read more...] about Teleflex to separate into two publicly traded companies

Teleflex wins FDA clearance for perfusion balloon for PTCA

By

Teleflex (NYSE: TFX) announced today that the FDA has granted 510(k) clearance for the company's Ringer perfusion balloon catheter for percutaneous transluminal coronary angioplasty (PTCA). The clearance expands Wayne, Pennsylvania–based Teleflex's interventional cardiology portfolio. It enables the company to offer what it says is the only … [Read more...] about Teleflex wins FDA clearance for perfusion balloon for PTCA

Teleflex has a serious balloon catheter recall, 3 deaths linked to issue

By

The FDA says a recall of Teleflex (NYSE:TFX) intra-aortic balloon (IAB) catheter kits is Class I, the most serious kind of recall. Teleflex recalled its Arrow FiberOptix IAB catheter kit and Arrow UltraFlex IAB catheter kit. This recall is a correction, not a product removal. However, the issues related to the kits resulted in reports of 31 … [Read more...] about Teleflex has a serious balloon catheter recall, 3 deaths linked to issue

The worst catheter-based device recalls of 2023

By

The U.S. saw seven severe catheter-based device recalls in 2023, according to the FDA's medical device recall database. The agency in 2023 tagged 61 medical device recalls as Class I — the most serious level. For comparison, the FDA recalled 60 devices in 2022, of which four were related to catheter-based devices. Last year, the most serious … [Read more...] about The worst catheter-based device recalls of 2023

Teleflex extends Arrow ErgoPack system with hemodialysis, large bore catheters

By

Teleflex (NYSE:TFX) announced today that it released its Arrow ErgoPack complete kits with hemodialysis and large-bore catheters in the U.S. Wayne, Pennsylvania-based Teleflex launched this update to streamline insertion workflow for clinicians. The company also says it provides more options to suit their particular needs. Clinicians can now … [Read more...] about Teleflex extends Arrow ErgoPack system with hemodialysis, large bore catheters

Teleflex completes enrollment in percutaneous coronary intervention study

By

Teleflex (NYSE: TFX) announced today that it completed patient enrollment in its prospective multicenter Ringer PTCA study. Ringer PTCA is one of two clinical studies evaluating Teleflex's novel Ringer perfusion balloon catheter. The trial enrolled patients across seven leading complex percutaneous coronary intervention (PCI) centers in the U.S. … [Read more...] about Teleflex completes enrollment in percutaneous coronary intervention study